Clinical Trial Update: Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is testing a less intensive radiation regimen with chemotherapy for low-risk HPV-positive oropharyngeal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hpv-positive Oropharyngeal Squamous Cell Carcinoma
• Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Cancer of the Head and Neck, Oropharynx Cancer | Phase 2 | Status: RECRUITING